Tinavi Medical Technologies Co Ltd (688277) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.04x

Tinavi Medical Technologies Co Ltd (688277) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥928.31K (capex CN¥928.31K ) from operating cash flow of CN¥24.50 Million. Check 688277 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.04x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥928.31K
Capex + Investments

Operating Cash Flow

CN¥24.50 Million
CNY

Capital Expenditures

CN¥928.31K
CNY

Tinavi Medical Technologies Co Ltd Cash Flow Reinvestment Rate (2015–2019)

Historical reinvestment intensity for Tinavi Medical Technologies Co Ltd across 4 annual periods. Explore Tinavi Medical Technologies Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Tinavi Medical Technologies Co Ltd (2015–2019)

Year-by-year capital reinvestment analysis for Tinavi Medical Technologies Co Ltd. For live market cap and broader valuation context, see 688277 market cap.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2019 7.54x CN¥154.86 Million CN¥20.53 Million CN¥20.17 Million ▼ -55.5%
2018 16.95x CN¥222.95 Million CN¥13.15 Million CN¥27.36 Million ▲ +198.6%
2017 5.68x CN¥32.52 Million CN¥5.73 Million CN¥6.28 Million ▲ +14455.7%
2015 0.04x CN¥1.63 Million CN¥41.82 Million CN¥1.63 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow